VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+5.45%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$243M
AUM Growth
+$6.44M
Cap. Flow
-$3.44M
Cap. Flow %
-1.41%
Top 10 Hldgs %
7.68%
Holding
410
New
55
Increased
156
Reduced
186
Closed
11

Top Buys

1
BKCC
BlackRock Capital Investment Corporation
BKCC
$670K
2
ZLAB icon
Zai Lab
ZLAB
$520K
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$422K
4
DRD
DRDGold
DRD
$405K
5
SCM icon
Stellus Capital Investment Corp
SCM
$402K

Top Sells

1
AMRS
Amyris Inc.
AMRS
$1.28M
2
PRTA icon
Prothena Corp
PRTA
$971K
3
BNTX icon
BioNTech
BNTX
$787K
4
RUBY
Rubius Therapeutics, Inc
RUBY
$647K
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
$645K

Sector Composition

1 Healthcare 27.38%
2 Real Estate 18.81%
3 Energy 13.29%
4 Materials 10.7%
5 Utilities 10.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MAIN icon
176
Main Street Capital
MAIN
$5.93B
$462K 0.19%
11,253
+558
+5% +$22.9K
ENTA icon
177
Enanta Pharmaceuticals
ENTA
$188M
$461K 0.19%
10,483
-4,238
-29% -$186K
DCF
178
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$458K 0.19%
47,671
+11,054
+30% +$106K
KNSA icon
179
Kiniksa Pharmaceuticals
KNSA
$2.64B
$456K 0.19%
32,762
+17,348
+113% +$241K
BLW icon
180
BlackRock Limited Duration Income Trust
BLW
$548M
$451K 0.19%
26,496
+7,232
+38% +$123K
SRPT icon
181
Sarepta Therapeutics
SRPT
$1.96B
$451K 0.19%
5,798
+2,112
+57% +$164K
FOLD icon
182
Amicus Therapeutics
FOLD
$2.51B
$449K 0.18%
46,576
+20,375
+78% +$196K
ACAD icon
183
Acadia Pharmaceuticals
ACAD
$4.25B
$447K 0.18%
18,330
+6,326
+53% +$154K
HRMY icon
184
Harmony Biosciences
HRMY
$2.07B
$440K 0.18%
15,603
+281
+2% +$7.92K
GBT
185
DELISTED
Global Blood Therapeutics, Inc.
GBT
$434K 0.18%
12,396
-2,258
-15% -$79.1K
BIIB icon
186
Biogen
BIIB
$20.8B
$426K 0.18%
1,229
-1,321
-52% -$458K
EVF
187
Eaton Vance Senior Income Trust
EVF
$101M
$422K 0.17%
62,116
+19,923
+47% +$135K
CERE
188
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$422K 0.17%
+16,484
New +$422K
OCSL icon
189
Oaktree Specialty Lending
OCSL
$1.22B
$417K 0.17%
20,794
-7,753
-27% -$155K
NTLA icon
190
Intellia Therapeutics
NTLA
$1.29B
$412K 0.17%
2,542
-3,219
-56% -$522K
ESPR icon
191
Esperion Therapeutics
ESPR
$534M
$410K 0.17%
19,398
-1,759
-8% -$37.2K
EXEL icon
192
Exelixis
EXEL
$10.1B
$400K 0.16%
21,937
-8,495
-28% -$155K
BRW
193
Saba Capital Income & Opportunities Fund
BRW
$350M
$393K 0.16%
41,739
+12,016
+40% +$113K
SAGE
194
DELISTED
Sage Therapeutics
SAGE
$389K 0.16%
6,853
-1,999
-23% -$113K
TBPH icon
195
Theravance Biopharma
TBPH
$713M
$387K 0.16%
26,643
-6,228
-19% -$90.5K
FCRD
196
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$337K 0.14%
73,954
+16,172
+28% +$73.7K
MRCC icon
197
Monroe Capital Corp
MRCC
$163M
$332K 0.14%
30,911
+5,996
+24% +$64.4K
OXSQ icon
198
Oxford Square Capital
OXSQ
$171M
$330K 0.14%
67,197
+6,541
+11% +$32.1K
SUNS
199
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$330K 0.14%
21,707
+6,188
+40% +$94.1K
EDIT icon
200
Editas Medicine
EDIT
$240M
$329K 0.14%
5,806
+922
+19% +$52.2K
6 7
8
9 10